These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 20864805)

  • 1. Therapeutic antibodies directed at G protein-coupled receptors.
    Hutchings CJ; Koglin M; Marshall FH
    MAbs; 2010; 2(6):594-606. PubMed ID: 20864805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.
    Hutchings CJ; Koglin M; Olson WC; Marshall FH
    Nat Rev Drug Discov; 2017 Sep; 16(9):787-810. PubMed ID: 28706220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of therapeutic antibodies to G protein-coupled receptors and ion channels: Opportunities, challenges and their therapeutic potential in respiratory diseases.
    Douthwaite JA; Finch DK; Mustelin T; Wilkinson TC
    Pharmacol Ther; 2017 Jan; 169():113-123. PubMed ID: 27153991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of antibody-based therapeutics targeting G protein-coupled receptors: an update.
    Hutchings CJ
    Expert Opin Biol Ther; 2020 Aug; 20(8):925-935. PubMed ID: 32264722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.
    Mujić-Delić A; de Wit RH; Verkaar F; Smit MJ
    Trends Pharmacol Sci; 2014 May; 35(5):247-55. PubMed ID: 24690241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of functional monoclonal antibodies targeting G-protein-coupled receptors and ion channels.
    Wilkinson TC
    Biochem Soc Trans; 2016 Jun; 44(3):831-7. PubMed ID: 27284048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A robust antibody discovery platform for difficult-to-express G protein-coupled receptors.
    Kim NH; Kang S; Park GH; Shim G; Kang TH; Yu YG
    Protein Sci; 2023 Jan; 32(1):e4520. PubMed ID: 36419382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein coupled receptors signaling pathways implicate in inflammatory and immune response of rheumatoid arthritis.
    Shu J; Zhang F; Zhang L; Wei W
    Inflamm Res; 2017 May; 66(5):379-387. PubMed ID: 27878579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
    Wold EA; Chen J; Cunningham KA; Zhou J
    J Med Chem; 2019 Jan; 62(1):88-127. PubMed ID: 30106578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs.
    De Groof TWM; Bobkov V; Heukers R; Smit MJ
    Mol Cell Endocrinol; 2019 Mar; 484():15-24. PubMed ID: 30690070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of G protein-coupled receptor-blocking monoclonal antibodies as therapeutic agents for cancers.
    Herr DR
    Int Rev Cell Mol Biol; 2012; 297():45-81. PubMed ID: 22608557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S; Bordoloi M; Sarmah R
    Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput screening (HTS) in identification new ligands and drugable targets of G protein-coupled receptors (GPCRs).
    Wang D; Li Y; Zhang Y; Liu Y; Shi G
    Comb Chem High Throughput Screen; 2012 Mar; 15(3):232-41. PubMed ID: 22221056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structural Life Science towards the Regulation of Selective GPCR Signaling].
    Kobayashi T
    Yakugaku Zasshi; 2016; 136(2):179-84. PubMed ID: 26831790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies detecting and modulating GPCRs outside in and inside out.
    Heukers R; De Groof TWM; Smit MJ
    Curr Opin Cell Biol; 2019 Apr; 57():115-122. PubMed ID: 30849632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPCRs: Emerging anti-cancer drug targets.
    Nieto Gutierrez A; McDonald PH
    Cell Signal; 2018 Jan; 41():65-74. PubMed ID: 28931490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an Antigen-Antibody Co-Display System for Detecting Interaction of G-Protein-Coupled Receptors and Single-Chain Variable Fragments.
    Zhang Y; Wu BJ; Yu X; Luo P; Ye H; Yu Y; Han W; Li J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies.
    Ju MS; Jung ST
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cell-cell interaction format for selection of high-affinity antibodies to membrane proteins.
    Yang Z; Wan Y; Tao P; Qiang M; Dong X; Lin CW; Yang G; Zheng T; Lerner RA
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):14971-14978. PubMed ID: 31285332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.